In-Home Drug Testing
A Review of Drug Testing Products
Christopher Altman, PharmD, shares the pros and cons of the available drug testing products.
Learn More about Clinical Roles
Latest News

The Challenges Facing Pharmacy
Walter Wong, PharmD, owner of Green Valley Pharmacy in Rancho Cucamongo, CA speaks to Pharmacy Times about low insurance reimbursement, exclusive contracts, and the increase in insurance processing fees as the current challenges to the pharmacy profession today. 
Three abstracts that evaluate the efficacy and safety of cantharidin (VP-102) were presented by Verrica Pharmaceuticals at the 39th Annual Fall Clinical Dermatology Conference in Las Vegas, Nevada.
 
Selecting SQ Formulation for a Patient
Factors that inform the decision to stratify patients to subcutaneous formulations.
Interactions Between Emergency Contraception and Other Hormonal Contraceptives
One highlight of the American Society for Emergency Contraception (ASEC) EC Jamboree was the key clinical discussions centered on drug interactions between emergency contraception and other hormonal contraceptives, including ulipristal acetate.
Prostate cancer prevention, irinotecan-induced diarrhea, smoking cessation, and more.
PUTT: Pharmacists United for Truth and Transparency
Community Pharmacy Consultant Bruce Kneeland talks with independent pharmacy owner Teresa Dickinson, RPh, about the work of Pharmacists United for Truth and Transparency.
Cheating Issue Invalidates Pharmacy Practice Exam
Pending results of the California Practice Standards and Jurisprudence Exam (CPJE) have been invalidated for 1400 applicants that recently took the test, due to a cheating issue.
Treatment depends on the patient, but adherence to the ever-changing guidelines is key.
The open-label Phase 2 trial looked to expand treatment for patients with newly diagnosed and persistent immune thrombocytopenia.
Upadacitinib Shows Promise for Treating Rheumatoid Arthritis
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) agreed on a positive opinion for AbbVie’s upadacitinib (RINVOQ), according to the company.
Top news of the week from Specialty Pharmacy Times.
Top news of the day from across the health care landscape.
 
 
+ Load More

Explore More About Pharmacy Times